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Abstract 
Purpose: To assess if intratumoral blood circulation parameters from dynamic susceptibility contrast (DSC) MRI and dy-
namic CT deliver comparable results and to compare tumor-related changes in regional cerebral blood flow (rCBF) and re-
gional cerebral blood volume (rCBV) with arterial, intratumoral, and venous transition detected with digital subtraction 
angiography (DSA). 
Patients and Methods: Ten patients with cerebral gliomas were prospectively studied with DSC-MRI, dynamic CT and DSA. 
Tumor areas were segmented and perfusion maps for rCBF, rCBV, and mean transit time (MTT) were computed from DSC-MRI 
and dynamic CT. Arterial circulation time (ACT), intermediate circulation time (ICT), and venous appearance time (VAT) 
were measured with DSA. Asymmetry indices (AIs) were calculated for MRI- and CT-based perfusion values, for ICT and VAT 
and compared among each other. 
Results: DSC-MRI and dynamic CT yielded comparable AI values for rCBF (MRI: 39.5 ± 20.4, CT: 36.0 ± 17.9, Pearson’s 
correlation r2 = 0.91) and rCBV (MRI: 44.6 ± 20.9 vs. CT: 40.9 ± 16.3, r2 = 0.84). The MTT AI (MRI: –4.7 ± 11.2 vs. CT: –0.5 ± 
10.4, r2 = 0.47) showed only a weak correlation. ICT correlated with rCBV (ICT: 38.4 ± 14.7, r2 = 0.59, and dynamic CT: 
r2 = 0.81) and VAT with rCBF (VAT: 31.7 ± 17.6, r2 = 0.73, and dynamic CT: r2 = 0.87), but not with MTT. 
Conclusion: CT and MRI methods provide consistent information about tumor vascularity of cerebral gliomas in accor-
dance with DSA. 
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Durchblutung zerebraler Gliome. Eine Studie mit DSA, Perfusions-CT und MRT 
Zusammenfassung 
Ziel: Vergleichsstudie zur Perfusionsmessung mittels CT- und MR-Perfusion bei Hirntumoren mit der Fragestellung, in-
wieweit beide Schnittbildverfahren bezüglich der Parameter regionaler zerebraler Blufluss (rCBF), regionales zerebrales 
Blutvolumen (rCBV) und mittlere Transitzeit (MTT) vergleichbare Ergebnisse zeigen. Die Ergebnisse werden mit den dyna-
mischen Untersuchungsergebnissen der digitalen Subtraktionsangiographie (DSA) verglichen. 
Patienten und Methodik: Zehn Patienten mit hirneigenen Tumoren wurden prospektiv mittels MR-Perfusion, CT-Perfu-
sion und DSA untersucht. Die Tumoren wurden segmentiert. In den segmentierten Arealen wurden rCBF, rCBV und MTT 
aus den Daten beider Modalitäten berechnet. Die arterielle Zirkulationszeit (ACT), intermediäre Zirkulationszeit (ICT) und 
venöse Anflutungszeit (VAT) wurden mittels DSA bestimmt. Regionenbasierte Asymmetrieindizes wurden für die CT- und 
MR-Perfusion, für ICT und VAT berechnet und verglichen. 
Ergebnisse: MR- und CT-Perfusion lieferten vergleichbare Ergebnisse für rCBF (MRT: 39,5 ± 20,4, CT: 36,0 ± 17,9, Pearson-
Korrelation r2 = 0,91) und rCBV (MRT: 44,6 ± 20,9 vs. CT: 40,9 ± 16,3, r2 = 0,84). Der Asymmetrieindex für MTT (MRT: –4,7 ± 
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Introduction 
In clinical practice, computed tomography (CT) and 
magnetic resonance imaging (MRI) are the investiga-
tions of choice in the evaluation of brain tumors [1–3]. 
Angiographic techniques for the detection of neovascu-
larity or arteriovenous shunting [4] and brain perfusion 
techniques like dynamic susceptibility contrast-(DSC-) 
MRI and dynamic CT may assist in distinguishing high-
grade from low-grade tumors [5, 6]. The detection of 
early opacification of a tumor-draining vein and the dy-
namics of tumor hypervascularity are still useful obser-
vations to determine tumor grading without biopsy, es-
pecially when the tumor is located in an eloquent region 
of the brain. Several studies have demonstrated the cor-
relation between microvessel density and increased rel-
ative cerebral blood volume in high-grade tumors with 
DSC-MRI [7–10]. To a lesser extent, the dynamic CT 
approach has been used in animal models and clinical 
practice [11, 12]. Yet, only few studies have focused on 
the comparability and reproducibility of different brain 
perfusion techniques in brain tumor imaging [13]. The 
routine use of CT in initial neuroradiologic diagnostics 
as well as its widespread clinical availability make dy-
namic CT a useful method to generate parametric maps 
of regional cerebral blood flow (rCBF) and regional ce-
rebral blood volume (rCBV) for tumor grading. 
The calculation of rCBF and rCBV according to the 
indicator-dilution theory [14], which is the basis of most 
commercially available software programs today, is lim-
ited due to the disruption of the blood-brain barrier and 
may lead to an overestimation of CBF and CBV. Be-
yond complex calculations of fractional plasma volume 
and vascular transfer constant [15], digital subtraction 
angiography (DSA) offers the advantage of directly in-
vestigating the increased tissue perfusion and its influ-
ence on intratumoral blood velocity with a high tempo-
ral and spatial resolution method. Comparative studies, 
however, which investigate the vascularity of cerebral 
gliomas with different parametric imaging techniques 
and DSA, do not exist. The purpose of the study was 
to test if (1) intratumoral blood circulation parameters 
are comparable between DSC-MRI and dynamic CT in 
a single-compartment model, and (2) if tumor-related 
relative changes of rCBF and rCBV in DSC-MRI and 
dynamic CT match the arterial, intratumoral and ve-
nous transition as determined from DSA. 
Patients and Methods 
Patients 
Ten patients, five women and five men, aged between 
44 and 78 years (mean age 57.1 years), with suspected 
gliomas, as detected with conventional MRI (Table 1), 
were prospectively studied with DSC-MRI, dynamic 
CT and DSA. Informed consent was obtained from 
every patient according to the rules of the local ethics 
committee. All patients had clinical findings suggestive 
either of increased intracranial pressure or a focal neu-
rologic deficit. All patients underwent DSC-MRI and 
dynamic CT on the same day. DSA was performed on 
the following day in all patients. Histological grading 
using stereotaxy or open tumor resection was done in 
seven patients. Two patients were histologically diag-
nosed with oligodendroglioma (WHO grade II and 
III), one patient with anaplastic astrocytoma (WHO 
grade III), and four patients with glioblastoma (WHO 
grade IV). Yet another three patients were diagnosed 
with glioblastoma (WHO grade IV) based on MRI 
findings, the detection of an early tumor-draining vein 
with DSA, and clinical and MRI follow-up. Histologi-
cal confirmation was not obtainable in these cases due 
to unresectable tumors located in eloquent areas of the 
brain where even stereotactic biopsy was considered to 
be associated with an intolerable risk of periprocedural 
complications. These patients were treated with com-
bined irradiation and chemotherapy. Although tumor 
grading is based on pathohistological evaluation, the 
combination of MRI and DSA has been used to ap-
proximate tumor grade of gliomas for many years [16]. 
11,2 vs. CT: –0,5 ± 10,4, r2 = 0,47) zeigte lediglich eine schwache Korrelation zwischen den Modalitäten. Die ICT korrelierte 
mit dem rCBV (ICT: 38,4 ± 14,7, r2 = 0,59, CT: r2 = 0,81) und die VAT mit dem CBF (VAT: 31,7 ± 17,6, r2 = 0,73, CT: r2 = 
0,87), jedoch nicht mit der MTT. 
Schlussfolgerung: Die Perfusionsmessung intrazerebraler Tumoren mittels CT und MRT liefert vergleichbare Ergebnisse, 
auch in Übereinstimmung mit der DSA. 
Schlüsselwörter:  Perfusions-CT · MRT · Angiographie · Gliom · Grading  
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During follow-up of the patient cohort, both patients 
with suspected grade II did not show any signs of dedif-
ferentiation up to now. All patients who presented with 
suspected grade IV glioma died from their brain tumor 
within 1 year after the MRI, CT, and DSA studies, thus 
further supporting the suspected diagnosis post hoc. 
The classification and grading applied in this study are 
based on the current WHO classification of nervous 
system tumors [17]. 
MR and CT Image Acquisition 
MRI was performed on a 1.5-T Siemens Sonata system 
(Siemens Medical Systems, Erlangen, Germany). A dy-
namic series was performed after bolus injection of 10 ml 
Gadovist® 1.0 (Bayer Schering Pharma, Baar, Switzer-
land) acquiring 40 images in twelve adjacent slices us-
ing an adapted 2-D echoplanar imaging sequence (slice 
thickness 5 mm; TR 1.44 s, TE 47 ms; FA 90°, FOV 
230 × 230 mm, matrix 128 × 128 interpolated to 256 × 
256 for postprocessing). Total acquisition time was 80 s. 
The CT studies were performed on a GE Light-speed 
QX/I 8 slice multislice scanner (General Electric, Mil-
waukee, WI, USA). A dynamic contrast-enhanced cine 
scan (80 kV, 200 mA) was performed after bolus injec-
tion of 40 ml of a high-iodine-concentration nonionic 
contrast agent (Iomeron® 400, Bracco SA, Milan, Italy) 
with an iodine concentration of 400 mg/ml, as reported 
previously [18]. The studies were acquired in two adja-
cent 10-mm sections with a temporal resolution of 1 s 
over a period of 45 s. 
Angiography  
DSA was performed on a biplane angiographic X-ray 
system (Toshiba KXO-80C & 80D with a Toshiba DFP 
2000/A image processing unit, Tokyo, Japan) by the same 
investigator. DSA images were acquired in standard (an-
teroposterior and lateral view) and oblique projections 
with a time resolution of 0.4 s. Image matrix was 1,024 × 
1,024 with a 12" image intensifier. No complications dur-
ing or after (in relation to) DSA were reported. 
Intraarterial four-vessel selective DSA was per-
formed in local anesthesia over conventional 6-F 
sheaths (Terumo Corp., Tokyo, Japan) via the right or 
left femoral artery with dedicated 5.5-F catheters (Cook 
JB-2, Bjaevrskov, Denmark). Selective DSA (83–86 kV, 
125 mA) was performed by selective injections of a non-
ionic contrast agent (Iopamiro® 300, Bracco SAy) into 
both common carotid and vertebral arteries at a flow 
rate of 5 ml/s. Ta
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Postprocessing and Analysis of Scans 
The parameter maps used for the assessment of cere-
bral hemodynamics included rCBF, rCBV, and mean 
transit time (MTT). These were calculated according to 
the indicator-dilution model for both imaging modali-
ties [19]. The parameter maps were computed for both 
DSC-MRI and dynamic CT with an in-house developed 
application written in JAVA-2 that uses a singular value 
decomposition-(SVD-)based algorithm [20]. The appli-
cation was specifically developed to handle perfusion 
imaging data of both imaging modalities.
Regions of interest (ROIs) in the tumor were then 
segmented semiautomatically from rCBF, rCBV and 
MTT maps, including solely regions with increased 
intensity thresholds. For DSC-MRI and dynamic CT 
evaluation, two ROIs were placed semiautomatically in 
a corresponding scan for rCBF, rCBV, and MTT. The 
first ROI was drawn to mark the tu-
mor outline, excluding the necrotic 
core in highly malignant gliomas. 
The second ROI of similar volume 
as the first was applied contralater-
ally into the nonaffected white mat-
ter through a mirroring function with 
manual correction (Figure 1). In 
cases where the neoplasm involved 
both hemispheres of the brain and 
mirroring to the corresponding con-
tralateral region was not possible, 
regions of comparable perfusion 
values within healthy tissue in the 
frontal or parietal lobe were used for 
internal reference. In order to com-
pare the individual perfusion maps 
in different vascular areas for every 
patient, a relative cerebral transit 
time, blood flow and volume ratio 
was calculated from all mean DSC-
MRI and dynamic CT-based perfu-
sion values. Since we do not have 
the possibility to absolutely quantify 
CT and MR perfusion values, we 
have chosen to use the asymmetry 
index (AI) to compare both meth-
ods. The methodological advantage 
of using these indices is that they are 
inherently independent of specific 
machines, protocols, or contrast ki-
netics [21, 22]. Arterial, parenchy-
mal, and venous phases in DSA were estimated from 
direct inspection of the high-resolution DSA images on 
a PACS workstation (Figures 2a and 2b). The transit 
time between the monitored points was calculated with 
a temporal resolution of 0.4 s (2.5 frames/s) as follows: 
arterial circulation time (ACT) from the start of arte-
rial filling of the cavernous part of the internal carotid 
artery to the time the terminal arterial branches were 
opacified, intermediate circulation time (ICT) from the 
end of the arterial filling to the beginning of the venous 
phase, and venous appearance time (VAT) from maxi-
mum arterial opacification to the appearance of con-
trast medium in the cortical veins [23]. Separate calcu-
lations were performed for the unaffected hemisphere, 
the affected hemisphere and the tumor region itself. 
These parameters were directly compared between the 
middle cerebral arteries (MCA) of the left and right 
Figure 1. Parametric perfusion maps of patient # 7. Increased rCBF and rCBV are observed in 
both DSC-MRI and dynamic CT. According to the higher spatial resolution of the dynamic CT 
images, the hyperperfused tumor rim is better resolved. 
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hemisphere if the tumor did not cross the hemisphere, 
and between the anterior (ACA) and middle cerebral 
arteries if the tumor crossed the midline. Furthermore, 
intratumoral arterial, parenchymal, and venous opacifi-
cation times as defined above were compared with the 
respective parameters in the contralateral hemisphere. 
To compare the time course of the angiogram with the 
results of the parametric perfusion maps from DSC-
MRI and dynamic CT, a relative AI [(affected – unaf-
fected region)/(affected + unaffected region)*100] was 
calculated for every parameter. 
Three board-certified neuroradiologists blinded 
to the histological results reviewed and discussed all 
DSC-MRI, dynamic CT and DSA studies until consen-
sus was obtained. Statistical analysis included Student’s 
two-tailed t-test for comparison of the perfusion-based 
pixel intensity values of DSC-MRI, dynamic CT and the 
circulation times of DSA. Pearson’s correlation coeffi-
cients were calculated to test the correlation between 
the perfusion parameters obtained from the two imag-
ing modalities and ACT, ICT, and VAT. 
Results 
Dynamics of MR versus CT Perfusion Studies 
All ten patients received DSC-MRI and dynamic CT 
on the same day. There was an excellent correlation 
between the rCBF AI and rCBV AI values calculated 
from DSC-MRI and dynamic CT. In all cases, asym-
metric perfusion was detected in DSC-MRI as well as in 
dynamic CT relative to normal white matter (Table 1). 
Perfusion imaging in one patient with a grade II tumor 
revealed only mild intratumoral hyperperfusion com-
pared to contralateral white matter on DSC-MRI and 
dynamic CT. Excellent correspondence between DSC-
MRI and dynamic CT was obtained from the rCBF 
maps (MRI: mean AI = 39.5, SD ± 20.4, CT: mean AI 
36.0 ± 17.9, Pearson’s correlation r2 = 0.91). rCBV AI 
values were: MRI: 44.6 ± 20.9 versus CT: 40.9 ± 16.3, 
r2 = 0.84. For the MTT AI (MRI: –4.7 ± 11.2 vs. CT: –0.5 
± 10.4, r2 = 0.47), there was only a weak intermodality 
correlation. 
Dynamics of DSA 
All ten patients received DSA 1 day after DSC-MRI 
and dynamic CT. The intratumoral vessels of all patients 
showed increased tortuosity and increased microvascu-
lar density. Patients 4–10, who had grade IV gliomas, 
showed aberrant and early venous filling during the ar-
terial phase of the angiogram. The ACT values did not 
show any relevant differences between the unaffected 
hemisphere and the tumor itself (p = not significant). 
ICT was significantly reduced in the capillary network 
of the tumor (p < 0.0001), and the extratumoral vessels 
of the affected hemisphere (p = 0.001). VAT showed an 
accelerated arteriovenous bolus passage in the affected 
hemisphere (p = 0.0003) and the tumor (p = 0.002), indi-
cating an increased tumor flow rate (Table 2). 
Correlations between DSC-MRI, Dynamic CT 
and DSA 
Pearson’s correlation coefficient was calculated for dif-
ferences in the relative asymmetry of different perfusion 
parameters between the tumor region and the contra-
lateral, unaffected hemisphere. To compare the values 
Figures 2a and 2b. The lateral view of the DSA shows the begin of the 
parenchymal phase (a, arrows) of the tumor and the early opacifica-
tion of the venous drainage (b, arrows), indicating a neovascularized 
glioblastoma multiforme (patient # 7). 
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of the parametric DSC-MRI and dynamic CT maps with 
the temporal dynamics of tumor hypervascularity in 
DSA, an AI was calculated for ICT and VAT. Best cor-
relation was achieved between ICT, an indicator for the 
vascular volume of the capillary network, and the para-
metric rCBV maps: ICT: 38.4 ± 14.7, DSC-MRI: 44.6 ± 
20.9, Pearson’s correlation r2 = 0.59, and dynamic CT: 
40.9 ± 16.3, Pearson’s correlation r2 = 0.81. The correla-
tion between the duration of the arterial and capillary 
stain (VAT) and the parametric rCBF maps was: VAT: 
31.7 ± 17.6, DSC-MRI: 39.5 ± 20.4, Pearson’s correlation 
r2 = 0.73, and dynamic CT 36.0 ± 17.9, Pearson’s correla-
tion r2 = 0.87 (Table 3, Figure 3). There was, however, 
no correlation between MTT and ICT or VAT: ICT: 
38.4 ± 14.7, DSC-MRI: –4.7 ± 11.6, 
Pearson’s correlation r2 = 0.12, and 
dynamic CT: –0.5 ± 10.4, Pearson’s 
correlation r2 = 0.07; VAT: 31.7 ± 
17.6, DSC-MRI: –4.7 ± 11.6, Pear-
son’s correlation r2 = 0.02, and dy-
namic CT –0.5 ± 10.4, Pearson’s 
correlation r2 = 0.12 (Table 3, Fig-
ure 3). 
Discussion 
Derangements of the cerebral he-
modynamics almost always occur 
in association with intracranial tu-
mors. Such hemodynamic changes 
can be evaluated either by DSA or 
by parametric perfusion imaging 
techniques [24–26]. DSA is not gen-
erally used in the diagnostic work-up of brain tumors, 
some neurosurgeons, however, prefer to have informa-
tion about a tumor’s arterial supply, venous drainage, 
and compression of adjacent major intracranial ves-
sels in high spatial resolution (< 200 µm), which can be 
achieved by catheter angiography only, to help them in 
planning an operative or stereotactic procedure. While 
DSC-MRI techniques have been widely used for clini-
cal routine during the last few years, there is still limited 
use of dynamic CT because of its limitations regarding 
covered volume, exposition to ionizing radiation, and 
iodinated contrast agents. Compared to DSC-MRI, 
however, dynamic CT has shown advantages in the de-
tection of tumor angiogenesis, according to the linear 
Table 2. DSA-related hemodynamic parameters for the unaffected and affected hemisphere versus tumor. ACT: arterial circulation time; ICT: inter-
mediate circulation time; VAT: venous appearance time. 
Patient  ACT (s)    ICT (s)    VAT (s)   
# Unaffected Affected Tumor  Unaffected  Affected Tumor Unaffected  Affected Tumor 
  1 2.0 2.0 1.6 2.0 2.0 1.6 4.4 4.4 4.0 
  2 1.6 1.6 1.6 2.8 2.0 1.6 6.0 6.0 4.0 
  3 1.6 2.0 2.8 2.4 2.4 1.2 4.4 4.8 3.2 
  4 1.2 1.2 2.0 1.6 0.8 0.8 3.2 2.4 2.0 
  5 1.2 1.2 1.2 3.2 3.2 1.2 6.0 4.8 4.8 
  6 1.2 1.2 1.6 3.2 2.8 1.2 5.2 4.8 1.6 
  7 1.2 1.6 1.2 2.4 2.8 1.2 4.8 5.2 1.6 
  8 1.2 1.6 1.6 2.0 2.0 0.8 4.0 3.6 1.6 
  9 1.6 1.6 1.2 2.0 1.2 0.4 4.4 3.6 1.6 
10 1.6 2.0 0.4 2.8 2.0 1.2 4.8 5.6 1.6 
ACT: unaffected vs. affected hemisphere p = 0.25; affected vs. tumor p = 0.72; unaffected vs. tumor p = 0.71. ICT: unaffected vs. affected hemisphere p = 0.28; affected vs. 
tumor p < 0.0001; unaffected vs. tumor p = 0.001. VAT: unaffected vs. affected hemisphere p = 0.65; affected vs. tumor p = 0.0003; unaffected vs. tumor p = 0.002 
Table 3. Mean AI ± SD and Pearson’s correlations between DSC-MRI, dynamic CT, DSA ICT and 
DSA VAT. AI: asymmetry index; CBF: cerebral blood flow; CBV: cerebral blood volume; CT: com-
puted tomgraphy; DSA: digital subtraction angiography; DSC: dynamic susceptibility contrast; 
ICT: intermediate circulation time; MRI: magnetic resonance imaging; MTT: mean transit time; 
SD: standard deviation; VAT: venous appearance time. 
Modality AI Modality AI Pearson’s correlation r2 
CBF DSC-MRI 39.5 ± 20.4 CBF dynamic CT 36.0 ± 17.9 0.91 
MTT DSC-MRI –4.7 ± 11.2 MTT dynamic CT –0.5 ± 10.4 0.47 
CBV DSC-MRI 44.6 ± 20.9 CBV dynamic CT 40.9 ± 16.3 0.84 
DSA ICT 38.4 ± 14.7 CBV DSC-MRI 44.6 ± 20.9 0.59 
DSA ICT 38.4 ± 14.7 CBV dynamic CT 40.9 ± 16.3 0.81 
DSA VAT 31.7 ± 17.6 CBF DSC-MRI 39.5 ± 20.4 0.73 
DSA VAT 31.7 ± 17.6 CBF dynamic CT 36.0 ± 17.9 0.87 
DSA ICT 38.4 ± 14.7 MTT DSC-MRI –4.7 ± 11.2 0.13 
DSA ICT 38.4 ± 14.7 MTT dynamic CT –0.5 ± 10.4 0.07 
DSA VAT 31.7 ± 17.6 MTT DSC-MRI –4.7 ± 11.2 0.02 
DSA VAT 31.7 ± 17.5 MTT dynamic CT –0.5 ± 10.4 0.12 
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relationship between contrast agent concentration and 
the CT attenuation coefficient, as well as to the absence 
of susceptibility artifacts [25]. Regarding the few studies 
and case series dealing with dynamic CT in the evalu-
ation of brain tumors, the rCBF and rCBV patterns in 
our series were consistently delineating higher-grade 
gliomas. Furthermore, the rCBF and rCBV patterns 
were consistent between DSC-MRI and dynamic CT. In 
all ten patients, rCBF and rCBV were increased at the 
site of the tumor. Although a number of studies have 
shown increased rCBV values in tumors with increased 
microvascular density [8, 27–29], no reliable data exist 
on the reproducibility of repeated rCBV measurements. 
While most of the studies used manually placed similar 
rectangular or circular ROIs in the tumor to compare 
the attenuation values, we have chosen individually ap-
plicable polygonal ROIs, fitted to the individual extent 
of the hyperperfused tumor areas. With this approach, 
we have excluded necrotic regions 
and edema neighboring the angio-
genetic tumor areas. Furthermore, 
we were able to apply approximate-
ly the same ROIs to the respective 
slices on dynamic CT and DSC-MRI 
to enable intermodal comparisons, 
which revealed strong correlations 
between both methods. 
A comparison between para-
metric maps and angiographic find-
ings is, by contrast, more difficult 
to achieve. Given the hypothesis of 
rCBV being the imaging analog of 
microvascular density [30], which is 
used in histopathologic evaluation, 
changes in the capillary passage time 
as measured with ICT should either 
indicate an increased tumor bed 
(prolonged ICT) or an early wash-
out of the capillary stain (shortened 
ICT) by arteriovenous shunting, 
indicating tumor dedifferentiation. 
In our series, we found an acceler-
ated ICT in the tumor in all patients. 
There was a strong correlation be-
tween ICT and rCBV in both DSC-
MRI and dynamic CT. The cerebral 
blood flow is more complex to detect 
on DSA, and different attempts have 
been made to quantify rCBF with di-
rect inspections of serial angiograms 
and time-density techniques. Some 
investigators have observed that ar-
terial flow correlates well with the 
perfusion of the cerebral territory 
fed by that artery [31, 32]. As the an-
giographic cerebral circulation time 
has been shown to correlate with the 
fast component of CBF in healthy 
Figure 3. Correlations between DSC-MRI, dynamic CT, VAT and ICT. Best correlation is achieved 
for CBF between DSC-MRI and dynamic CT (r2 = 0.91) and between DSA VAT and CBF in dy-
namic CT (r2 = 0.87). 
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